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Necrotizing enterocolitis (NEC), a severe intestinal disease occurring in 5-10% of hospitalized 
preterm infants, is associated with exaggerated tissue responses to the gut microbiota. Mother’s 
milk decreases the risk of NEC, potentially due to bioactive compounds that modulate gut 
colonization and tissue responses. Human milk oligosaccharides (HMOS) are largely indigestible to 
infants but are found at concentrations up to 12 g/L in human breast milk, while only trace amounts 
are present in cow’s milk. Important biological functions other than nutritional have been 
documented for several HMOs such as prebiotic, anti-inflammatory or anti-microbial actions. 2’-
fucosyllactose (2’-FL), that accounts for 75% of the human milk HMOS, has been shown to have 
prebiotic effects on bifidobacteria while it potentially inhibit epithelial adhesion of pathogens due to 
structural homology with intestinal bacterial receptors. We hypothesized that a 2’-FL supplemented 
infant formula would modify the gut microbiota, decrease epithelial adhesion of pathogens and 
thereby reduce the risk of NEC. To test the hypothesis, we used a sensitive model with cesarean 
delivered preterm pigs that at a high proportion spontaneously develop NEC after 5 days of 
formula-feeding. 
 
Twentyone newborn preterm pigs were fitted with umbilical catheters and orogastric tubes. 
Parenteral nutrition and minimal boluses of formula (3 mL/kg/3h) was given for 48 h followed by 
full enteral feeding (15 mL/kg/3h) with control formula (FORM, n=11) or 2’-FL fortified formula 
(2FL, 5 g/L, n=10). To standardize initial gut colonization, maternal fecal bacteria (2.5×104 cfu) 
were given as an oral inoculum with the first minimal formula bolus. On day 5, all pigs were 
euthanized for tissue collection and NEC evaluation.  
 
Five 2’-FL-pigs (50%) and nine controls (82%) developed NEC (P=0.18) with a tendency to 
increased intestinal NEC-lesions in controls compared to 2’-FL-pigs (small intestine: 1.8±0.3 vs. 
1.4±0.2, P=0.36; colon: 2.7±0.6 vs. 1.5±0.5, P=0.14). A 40% reduction of anaerobic bacteria was 
observed in cecum contents of 2’-FL pigs compared to controls (1.6×1010±9.8×109 vs. 
2.7×1010±2.6×1010 cfu/mL) but the decrease was not significant (P=0.24). Bacterial density along 
the intestinal mucosa, as detected by fluorescence in situ hybridization of general bacteria, was 
similar between groups (P=0.68). Similarly, there were no significant effects of the 2’-FL on 
intestinal structure and function, as assessed by intestinal wet weight, proportion of mucosa, villus 
height, in vivo lactose uptake capacity and brush border enzyme activities (sucrase, maltase, lactase, 
peptididases).  
 
Adding 5 g/L 2’FL to infant formula, tended to decrease incidence and severity of NEC in preterm 
pigs. Since bacterial colonization and intestinal structural and functional parameters were not 
significantly affected, further investigations are needed to test if the given dose of 2’FL potentially 
modified tissue responses to colonizing bacteria and enteral feeding. It should further be 
investigated if other doses of 2’-FL may more efficiently alter bacterial colonization or mucosal 
responses to diets and bacteria and thereby increase NEC resistance in preterm neonates. 
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